2,6-Naphthyridin-1(2H)-one, 3,4-dihydro-

Modify Date: 2024-01-14 12:04:46

2,6-Naphthyridin-1(2H)-one, 3,4-dihydro- Structure
2,6-Naphthyridin-1(2H)-one, 3,4-dihydro- structure
Common Name 2,6-Naphthyridin-1(2H)-one, 3,4-dihydro-
CAS Number 58553-56-3 Molecular Weight 148.16200
Density N/A Boiling Point N/A
Molecular Formula C8H8N2O Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name 3,4-dihydro-2H-2,6-naphthyridin-1-one
Synonym More Synonyms

 Chemical & Physical Properties

Molecular Formula C8H8N2O
Molecular Weight 148.16200
Exact Mass 148.06400
PSA 41.99000
LogP 0.69630

 Synthetic Route

~27%

2,6-Naphthyridin-1(2H)-one, 3,4-dihydro- Structure

2,6-Naphthyridi...

CAS#:58553-56-3

Literature: NOVARTIS AG; Bock, Mark Gary; Gaul, Christoph; Gummadi, Venkateshwar Rao; Moebitz, Henrik; Sengupta, Saumitra Patent: US2014/45872 A1, 2014 ; Location in patent: Paragraph 1018 ;

~%

2,6-Naphthyridin-1(2H)-one, 3,4-dihydro- Structure

2,6-Naphthyridi...

CAS#:58553-56-3

Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1

~%

2,6-Naphthyridin-1(2H)-one, 3,4-dihydro- Structure

2,6-Naphthyridi...

CAS#:58553-56-3

Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1

~%

2,6-Naphthyridin-1(2H)-one, 3,4-dihydro- Structure

2,6-Naphthyridi...

CAS#:58553-56-3

Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1

~%

2,6-Naphthyridin-1(2H)-one, 3,4-dihydro- Structure

2,6-Naphthyridi...

CAS#:58553-56-3

Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1

~%

2,6-Naphthyridin-1(2H)-one, 3,4-dihydro- Structure

2,6-Naphthyridi...

CAS#:58553-56-3

Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1

~%

2,6-Naphthyridin-1(2H)-one, 3,4-dihydro- Structure

2,6-Naphthyridi...

CAS#:58553-56-3

Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1

~%

2,6-Naphthyridin-1(2H)-one, 3,4-dihydro- Structure

2,6-Naphthyridi...

CAS#:58553-56-3

Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1

~%

2,6-Naphthyridin-1(2H)-one, 3,4-dihydro- Structure

2,6-Naphthyridi...

CAS#:58553-56-3

Literature: Meiji Seika Kaisha, Ltd. Patent: EP1180514 A1, 2002 ; Location in patent: Example 104 ;

 Synonyms

3,4-dihydro-2H-[2,6]naphthyridin-1-one
Tetrahydro-2,6-naphthyridin-1-on
3,4-dihydro-2,6-naphthyridin-1(2H)-one
1,2,3,4-Tetrahydro-2,6-naphthyridin-1-on
1,2,3,4-TETRAHYDRO-2,6-NAPHTHYRIDIN-1-ONE